Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma

被引:14
|
作者
Brundler, MA
Harrison, JA
de Saussure, B
de Perrot, M
Pepper, MS
机构
[1] Univ Geneva, Med Ctr, Dept Clin Pathol, CH-1211 Geneva 4, Switzerland
[2] Univ Geneva, Med Ctr, Dept Morphol, CH-1211 Geneva 4, Switzerland
[3] Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England
[4] Unitas Hosp, NetCare Mol Med Inst, ZA-0140 Pretoria, South Africa
关键词
D O I
10.1136/jcp.2005.028118
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Oesophageal adenocarcinoma is an aggressive neoplasm with poor prognosis as a result of early lymph node metastasis. Aims: To measure lymphatic vessel density (LVD) in the neoplastic progression from Barrett's metaplasia to adenocarcinoma and determine whether LVD can predict the risk of cancer. In addition, to correlate LVD with lymph node metastasis and assess whether LVD could be used as a prognostic indicator for outcome or survival. Methods: LVD and microvascular density (MVD) were assessed after immunohistochemical staining of vessels in Barrett's metaplasia, dysplasia, and adenocarcinoma tissues and were correlated with clinicopathological features. Results: LVD was significantly reduced in adenocarcinoma, being half that seen in normal stomach/oesophagus or metaplasia/dysplasia. LVD did not correlate with tumour grade, stage, or clinical outcome; however, patients who had either lymph node metastasis or invasion of tumour cells into peritumorous lymphatic vessels had a significantly worse overall survival. MVD was also assessed as a prognostic marker; its increase appeared to be linked more with the development of Barrett's metaplasia than adenocarcinoma. Conclusions: The reduction in lymphatic vessel numbers was not useful for determining disease outcome in the patient group studied. It is the entry of tumour cells into pre-existing peritumorous lymphatic vessels that confers a significantly worse overall survival.
引用
收藏
页码:191 / 195
页数:5
相关论文
共 50 条
  • [41] Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma
    Fitzgerald, R. C.
    GUT, 2006, 55 (12) : 1810 - 1818
  • [42] Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma
    P Coyle
    G Mathew
    P A Game
    J C Myers
    J C Philcox
    A M Rofe
    G G Jamieson
    British Journal of Cancer, 2002, 87 : 533 - 536
  • [43] Sex hormone receptors in Barrett's oesophagus and adenocarcinoma
    Tiffin, N
    Suvarna, SK
    Trudgill, N
    Riley, SA
    JOURNAL OF PATHOLOGY, 2001, 193 : 22A - 22A
  • [44] Role of inflammation and T-cell response on Barrett's oesophagus progression to oesophageal adenocarcinoma
    Puccio, I.
    Khan, S. U. Rehman
    Butt, A.
    Graham, D.
    Patel, D.
    Sehgal, V.
    Novelli, M.
    Lovat, L.
    Rodriguez-Justo, M.
    Hamoudi, R.
    VIRCHOWS ARCHIV, 2016, 469 : S156 - S156
  • [45] Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus
    Holmberg, Dag
    Ness-Jensen, Eivind
    Mattsson, Fredrik
    El-Serag, Hashem B.
    Lagergren, Jesper
    EUROPEAN JOURNAL OF CANCER, 2017, 75 : 41 - 46
  • [46] Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma
    Coyle, P
    Mathew, G
    Game, PA
    Myers, JC
    Philcox, JC
    Rofe, AM
    Jamieson, GG
    BRITISH JOURNAL OF CANCER, 2002, 87 (05) : 533 - 536
  • [47] Reflux, Barrett's oesophagus and adenocarcinoma: Burning questions
    Wild, CP
    Hardie, LJ
    NATURE REVIEWS CANCER, 2003, 3 (09) : 676 - U3
  • [48] Reduced expression of αGlcNAc in Barrett's oesophagus adjacent to Barrett's adenocarcinoma - a possible biomarker to predict the malignant potential of Barrett's oesophagus
    Iwaya, Yugo
    Hasebe, Osamu
    Koide, Naohiko
    Kitahara, Kei
    Suga, Tomoaki
    Shinji, Akihiro
    Muraki, Takashi
    Yokosawa, Shuichi
    Yamada, Shigenori
    Arakura, Norikazu
    Tanaka, Eiji
    Nakayama, Jun
    HISTOPATHOLOGY, 2014, 64 (04) : 536 - 546
  • [49] Management of Barrett's oesophagus, dysplasia and early adenocarcinoma
    Ell, C
    Pech, O
    GASTROENTEROLOGY YESTERDAY - TODAY - TOMORROW: A REVIEW AND PREVIEW, 2005, 144 : 22 - 38
  • [50] Management of Barrett's oesophagus, dysplasia and early adenocarcinoma
    Pech, O
    Gossner, L
    May, A
    Ell, C
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2001, 15 (02) : 267 - 284